Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, ...

This year’s CES welcomes a new player. On January 6, Nebula Next made its debut at CES, officially unveiling the concept car ...

Discover the 10 key steps in developing new financial products, from concept to market launch, to understand their journey to ...

Discover how exit options in business can help minimize financial losses. Learn when and how to implement these strategies ...

Company Transitions from Infrastructure Buildout to Active Market Execution as Expanded 510(k) Review Enters Final ...

What trends do you see shaping the Wealth and Asset Management industry? We see three. The first is the continued growth of ...

Ripple confirms it has no IPO plans, citing strong finances, $500M raised, and a growth strategy focused on acquisitions and ...

L&T Semiconductor Technologies is expected to outline a partner-led expansion into cellular IoT modules at CES, positioning ...

Innovation ideas may include macaroni and cheese ramen and peanut butter and jelly energy bars. Product developers also are exploring combinations of flavors, like yuzu-gochujang hot wings, ...

To understand where we’re headed, it helps to break the AI landscape into four categories. When ChatGPT launched in late 2022 ...

What Microsoft’s 2026 Product Plans Reveal About Its AI Push Your email has been sent Microsoft’s 2026 product plans put AI front and center, shifting it from an optional add-on to a core layer across ...